Sectors
LAB
Standard BioTools Inc.
0.66
2 x 0.45
2 x 0.84
bid
ask
+
0.02
2.62%
2 @ 07:37 PM
0.67 +0.01 (1.69%)
| Ytd | -48.54% | |
| 1y | -47.72% |
0.64
day range
0.67
0.63
52 week range
1.72
| Open | 0.65 | Prev Close | 0.64 | Low | 0.64 | High | 0.67 | Mkt Cap | 258.59M |
| Vol | 1.76M | Avg Vol | 3.31M | EPS | -0.13 | P/E | N/A | Forward P/E | -8.50 |
| Beta | 1.57 | Short Ratio | 5.30 | Inst. Own | 73.29% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-03 | 50-d Avg | 0.79 | 200-d Avg | 1.08 | 1yr Est | 3.08 |
| Income Statement | |||
| Total Revenue | 20.10M | ||
| Revenues (USD) | 20.10M | ||
| Cost of Revenue | 9.57M | ||
| Gross Profit | 10.54M | ||
| Operating Expenses | 35.92M | ||
| Research and Development Expense | 1.98M | ||
| Selling, General and Administrative Expense | 16.39M | ||
| Operating Income | -25.39M | ||
| Income Tax Expense | 90.00K | ||
| Net Income | -26.76M | ||
| Net Income Common Stock | -26.76M | ||
| Net Income Common Stock (USD) | -26.76M | ||
| Consolidated Income | -26.76M | ||
| Net Income from Discontinued Operations | 5.23M | ||
| Earnings per Basic Share | -0.07 | ||
| Earnings per Basic Share (USD) | -0.07 | ||
| Earnings per Diluted Share | -0.07 | ||
| Earning Before Interest & Taxes (EBIT) | -26.67M | ||
| Earning Before Interest & Taxes (USD) | -26.67M | ||
| Weighted Average Shares | 390.88M | ||
| Weighted Average Shares Diluted | 390.88M | ||
| Balance Sheet | |||
| Cash and Equivalents | 270.03M | ||
| Cash and Equivalents (USD) | 270.03M | ||
| Investments | 273.97M | ||
| Investments Current | 206.69M | ||
| Investments Non-Current | 67.28M | ||
| Trade and Non-Trade Receivables | 15.75M | ||
| Current Assets | 516.87M | ||
| Property, Plant & Equipment Net | 39.55M | ||
| Total Assets | 627.22M | ||
| Debt Current | 5.62M | ||
| Total Debt | 28.09M | ||
| Current Liabilities | 56.80M | ||
| Debt Non-Current | 22.47M | ||
| Total Liabilities | 87.25M | ||
| Accumulated Retained Earnings (Deficit) | -1.16B | ||
| Accumulated Other Comprehensive Income | 1.18M | ||
| Shareholders Equity | 539.97M | ||
| Shareholders Equity (USD) | 539.97M | ||
| Assets Non-Current | 110.35M | ||
| Total Debt (USD) | 28.09M | ||
| Deferred Revenue | 18.06M | ||
| Inventory | 17.10M | ||
| Liabilities Non-Current | 30.45M | ||
| Trade and Non-Trade Payables | 9.55M | ||
| Tax Assets | 264.00K | ||
| Tax Liabilities | 823.00K | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 2.52M | ||
| Net Cash Flow from Financing | -138.00K | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 4.25M | ||
| Capital Expenditure | -344.00K | ||
| Net Cash Flow - Business Acquisitions and Disposals | 24.99M | ||
| Issuance (Purchase) of Equity Shares | 120.00K | ||
| Net Cash Flow from Investing | 14.41M | ||
| Net Cash Flow - Investment Acquisitions and Disposals | -10.24M | ||
| Net Cash Flow from Operations | -10.31M | ||
| Effect of Exchange Rate Changes on Cash | 294.00K | ||
| Share Based Compensation | 4.05M | ||